Search

Author/Creator Van Solingen-Ristea, Rodica

1. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies. (31st December 2020)

Authors:
Teichner, Paula; Wu, Sterling; Zhang, Feifan; Dorey, David; D'Amico, Ronald; Griffith, Sandy; Sutton, Kenneth; McCoig, Cynthia C; Upadhyay, Ojesh R; Polli, Joseph; Margolis, David; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William; Patel, Parul
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S544
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results. (31st December 2020)

Authors:
Smith, Graham; Henry, Keith; Podzamczer, Daniel; Masiá, Mar; Bettacchi, Christopher; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Sutton, Kenneth; Zhang, Feifan; McCoig, Cynthia C; Vandermeulen, Kati; Van Solingen-Ristea, Rodica; Spreen, William; Margolis, David
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S379
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 833. Efficacy and Safety of Long-Acting Cabotegravir + Rilpivirine in Participants with HIV/HCV Co-infection: ATLAS-2M 48-Week Results. (4th December 2021)

Authors:
D'Amico, Ronald; Benn, Paul; Thiagarajah, Shanker; Ford, Susan L; Birmingham, Eileen; Upadhyay, Ojesh R; Garside, Louise; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S508
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes. (4th December 2021)

Authors:
Taiwo, Babafemi O; Tan, Darrell; Patel, Parul; Teichner, Paula; Polli, Joseph; Garside, Louise; D'Amico, Ronald; Talarico, Christine L; Van Solingen-Ristea, Rodica; Baugh, Bryan; Spreen, William; Aboud, Michael; Bosse, Matthew
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials. (4th December 2021)

Authors:
Patel, Parul; Ford, Susan L; Baker, Mark; Meyer, Claudia; Garside, Louise; D'Amico, Ronald; Van Solingen-Ristea, Rodica; Crauwels, Herta; Polli, Joseph; Seal, Ciara; Thiagarajah, Shanker; Birmingham, Eileen; Spreen, William; Baugh, Bryan; Bosse, Matthew; Vannappagari, Vani
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2. (1st September 2022)

Authors:
Llibre, Josep M.; López Cortés, Luis Fernando; Aylott, Alicia; Wynne, Brian; Matthews, Jessica; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; van Wyk, Jean; Kahl, Lesley P.
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 91:Number 1(2022)
Page Start:
73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. (25th August 2021)

Authors:
Smith, Graham H R; Henry, W Keith; Podzamczer, Daniel; Masiá, Maria Del Mar; Bettacchi, Christopher J; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Montes-Ramírez, Maria Luisa; Stellbrink, Hans-Jürgen; Yazdanpanah, Yazdan; Richmond, Gary J; Sutton, Kenneth C; Zhang, Feifan; McCoig,...
Journal:
Open forum infectious diseases
Issue:
Volume 8:Number 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study. Issue 11 (November 2021)

Authors:
Orkin, Chloe; Bernal Morell, Enrique; Tan, Darrell H S; Katner, Harold; Stellbrink, Hans-Jürgen; Belonosova, Elena; DeMoor, Rebecca; Griffith, Sandy; Thiagarajah, Shanker; Van Solingen-Ristea, Rodica; Ford, Susan L; Crauwels, Herta; Patel, Parul; Cutrell, Amy; Smith, Kimberly Y; Vandermeulen, Kat...
Journal:
Lancet
Issue:
Volume 8:Issue 11(2021)
Page Start:
e668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Issue 10267 (19th December 2020)

Authors:
Overton, Edgar T; Richmond, Gary; Rizzardini, Giuliano; Jaeger, Hans; Orrell, Catherine; Nagimova, Firaya; Bredeek, Fritz; García Deltoro, Miguel; Swindells, Susan; Andrade-Villanueva, Jaime Federico; Wong, Alexander; Khuong-Josses, Marie-Aude; Van Solingen-Ristea, Rodica; van Eygen, Veerle; Crau...
Journal:
Lancet
Issue:
Volume 396:Issue 10267(2020)
Page Start:
1994
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Issue 11 (November 2021)

Authors:
Jaeger, Hans; Overton, Edgar T; Richmond, Gary; Rizzardini, Giuliano; Andrade-Villanueva, Jaime Federico; Mngqibisa, Rosie; Hermida, Antonio Ocampo; Thalme, Anders; Belonosova, Elena; Ajana, Faïza; Benn, Paul D; Wang, Yuanyuan; Hudson, Krischan J; Español, Carlos Martín; Ford, Susan L; Crauwels, ...
Journal:
Lancet
Issue:
Volume 8:Issue 11(2021)
Page Start:
e679
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗